To Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Gastric Cancer
To Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Gastric Cancer
Recruiting · NCT06504732 · Registry updated 2026-06-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| To Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Gastric Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric neoplasm, neoplasm, stomach disorder | Recruiting | Phase 2 / Phase 3 | 2026-06-05 | NCT06504732 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| SUNHO（China）BioPharmaceutical CO., Ltd. | 10 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Harbin Medical University Cancer Hospital | Harbin | China | 102 |
| The First Hospital of China Medical University | Shenyang | China | 1 |